UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

Breast cancer research and treatment, 2023-11, Vol.202 (1), p.73-81

2023

Volltextzugriff (PDF)

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study

Breast (Edinburgh), 2021-10, Vol.59, p.67-75

2021

Volltextzugriff (PDF)

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

The New England journal of medicine, 2018-07, Vol.379 (2), p.111-121

2018

Volltextzugriff (PDF)

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.390-399

2021

Volltextzugriff (PDF)

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial

Annals of surgery, 2022-11, Vol.276 (5), p.905-912

2022

Volltextzugriff (PDF)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial

Journal of the American College of Surgeons, 2023-02, Vol.236 (2), p.317-327

2023

Volltextzugriff (PDF)

Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways

Oncotarget, 2017-10, Vol.8 (46), p.80568-80588

2017

Volltextzugriff (PDF)

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

Breast cancer research and treatment, 2019-02, Vol.174 (1), p.1-13

2019

Volltextzugriff (PDF)

Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre

The breast journal, 2021-06, Vol.27 (6), p.521-528

2021

Volltextzugriff (PDF)

Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes

Critical reviews in oncogenesis, 2016, Vol.21 (5-6), p.333-351

2016

Volltextzugriff (PDF)

Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.269-283

2021

Volltextzugriff (PDF)

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score

Journal of personalized medicine, 2022-07, Vol.12 (7), p.1117

2022

Volltextzugriff (PDF)

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (3), p.734-741

1999

Volltextzugriff (PDF)

Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4892-4900

2001

Volltextzugriff (PDF)

The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal Kinase

Molecular and Cellular Biology, 2000-09, Vol.20 (18), p.6638-6645

2000

Volltextzugriff (PDF)

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

The New England journal of medicine, 2019-06, Vol.380 (25), p.2395-2405

2019

Volltextzugriff (PDF)

Fas expression and function in normal and malignant breast cell lines

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4791-4798

1996

Volltextzugriff (PDF)

Inhibition of NF-κB activity enhances TRAIL mediated apoptosis in breast cancer cell lines

Breast cancer research and treatment, 2000-11, Vol.64 (2), p.211-219

2000

Volltextzugriff (PDF)

cbl-3 : a new mammalian cbl family protein

Oncogene, 1999-06, Vol.18 (22), p.3365-3375

1999

Volltextzugriff (PDF)

cbl-b inhibits epidermal growth factor receptor signaling

Oncogene, 1999-03, Vol.18 (10), p.1855-1866

1999

Volltextzugriff (PDF)

The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells

Cancer research (Chicago, Ill.), 1996-09, Vol.56 (18), p.4236-4243

1996

Volltextzugriff (PDF)

Abstract P1-10-11: Pathological complete response after carboplatin-based neoadjuvant chemotherapy in triple negative breast cancer: The importance of stromal tumor infiltrating lymphocytes as a predictive biomarker

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-10-11

2020

Volltextzugriff (PDF)

The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12085-e12085

2019

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)

Publikationsform

Artikel
(67)
Tagungsberichte
(1)

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial

Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre

Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes

Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines

Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2

The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal Kinase

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Fas expression and function in normal and malignant breast cell lines

Inhibition of NF-κB activity enhances TRAIL mediated apoptosis in breast cancer cell lines

cbl-3 : a new mammalian cbl family protein

cbl-b inhibits epidermal growth factor receptor signaling

The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells

Abstract P1-10-11: Pathological complete response after carboplatin-based neoadjuvant chemotherapy in triple negative breast cancer: The importance of stromal tumor infiltrating lymphocytes as a predictive biomarker

The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC)

Aktive Filter

Suchergebnisse filtern